ABCL
ABCL

Abcellera Biologics Inc

NASDAQ · Life Sciences Tools & Services
$3.16
+0.38 (+13.67%)
Day Range $2.88 — $3.17
52W Range $1.89 — $6.52
Open$2.94
Previous Close$2.78
Day High$3.17
Day Low$2.88
52W High$6.52
52W Low$1.89
Volume
Avg Volume5.13M
Market Cap945.90M
P/E Ratio
EPS$-0.58
SectorLife Sciences Tools & Services
Analyst Ratings
Strong Buy
14 analysts
12 Buy 2 Hold 0 Sell
Price Target +1,318.0% upside
Current
$3.16
Target
$44.81
$32.90 $44.81 avg $56.58
Key Financials
FY 2026 FY 2025 FY 2025
Revenue 29.33M 68.99M 394.89M
Net Income -165,622,080 -350,564,139 57.89M
Profit Margin -564.8% -536.6% 14.7%
EBITDA -168,226,294 -375,858,370 91.93M
Free Cash Flow 65.77M
Rev Growth -57.5% -57.5% +5.6%
Debt/Equity 0.31
Life Sciences Tools & Services Peers
Symbol Name Price Change P/E Mkt Cap
TMO Thermo Fisher Scientific Inc $542.83 +0.09% 30.4 203.95B
DHR Danaher Corp $216.61 +0.40% 42.3 153.00B
A Agilent Technologies Inc $129.58 -0.05% 28.1 36.65B
IQV Iqvia Holdings Inc $187.49 +3.61% 23.5 31.93B
MTD Mettler-Toledo International $1,373.57 -0.67% 33.6 28.06B
WAT Waters Corp $381.29 +1.17% 34.3 22.22B
Next Earnings
Feb 24, 2026
After Market Close
15 days away
EPS Est: $-0.19
ABCL News

No news for ABCL yet

Quick Stats
Market Cap945.90M
P/E Ratio
EPS$-0.58
Volume
SectorLife Sciences Tools & Services